Form 4: RxSight CFO Shelley Thunen Executes Option and Sells Shares Under 10b5-1 Plan

Shelley Thunen, CFO of RxSight, Inc., exercised stock options and sold shares of common stock on March 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Shelley Thunen, the Chief Financial Officer of RxSight, Inc., executed a transaction involving the company's stock on March 1, 2024.
• Thunen exercised stock options to acquire 10,000 shares of common stock at a price of $15.5983 per share.
• Simultaneously, Thunen sold a total of 10,000 shares of common stock in multiple transactions at weighted average prices ranging from $54.945 to $57.0327.
• These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on September 14, 2023.
• After these transactions, Thunen directly owns 13,691 shares and indirectly owns 28,402 shares through a family trust.
• Thunen also directly owns 56,805 derivative securities in the form of stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a standard disclosure of insider trading activity under a pre-existing plan. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to have pre-arranged trading plans like Rule 10b5-1 to avoid accusations of trading on inside information. The market will likely interpret this as a standard part of executive compensation and portfolio management.

Key Dates